ZIAGEN - 53808-0811-1 - (abacavir sulfate)

Alphabetical Index


Drug Information of ZIAGEN

Product NDC: 53808-0811
Proprietary Name: ZIAGEN
Non Proprietary Name: abacavir sulfate
Active Ingredient(s): 300    mg/1 & nbsp;   abacavir sulfate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of ZIAGEN

Product NDC: 53808-0811
Labeler Name: State of Florida DOH Central Pharmacy
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020977
Marketing Category: NDA
Start Marketing Date: 20090701

Package Information of ZIAGEN

Package NDC: 53808-0811-1
Package Description: 1 TABLET, FILM COATED in 1 BLISTER PACK (53808-0811-1)

NDC Information of ZIAGEN

NDC Code 53808-0811-1
Proprietary Name ZIAGEN
Package Description 1 TABLET, FILM COATED in 1 BLISTER PACK (53808-0811-1)
Product NDC 53808-0811
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name abacavir sulfate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20090701
Marketing Category Name NDA
Labeler Name State of Florida DOH Central Pharmacy
Substance Name ABACAVIR SULFATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of ZIAGEN


General Information